Also, comparing the EBV+ NPC and EBV− NPC biopsies, the percentage of activated CD56+CD3− granzyme B+ NK cells was found to be lower for EBV+ NPC [65]. The gene discussed is GZMB; the disease is nasopharyngeal carcinoma.